Ads
related to: experimental prostate cancer drugs list- FAQs
Find Answers to Commonly
Asked Questions from Patients.
- Doctor Discussion Guide
Use This List and Come Prepared to
Discuss Options with Your Doctor.
- Starting Treatment
Learn How to Find a Specialty
Pharmacy to Obtain Treatment.
- Financial Assistance Info
Learn About Financial Support
Options for Eligible Patients.
- FAQs
Search results
Results from the WOW.Com Content Network
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
Prostate cancer: Myelosuppression, diarrhoea, kidney failure, hypersensitivity, severe GI reactions (including perforation, ileus, colitis, etc.; all rare) and peripheral neuropathy Docetaxel: IV: As above. Breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, squamous cell head and neck cancer and gastric cancer.
Seviteronel (developmental codes VT-464 and, formerly, INO-464) is an experimental cancer medication which is under development by Viamet Pharmaceuticals and Innocrin Pharmaceuticals for the treatment of prostate cancer and breast cancer. [1]
The candidate, JANX007, reduced prostate-specific (PSA) antigen levels in a majority of the 23 patients who received the drug, the company said late on Monday, adding that deeper reductions were ...
Pages in category "Experimental cancer drugs" The following 200 pages are in this category, out of approximately 262 total. This list may not reflect recent changes .
Experimental cancer drugs (262 P) D. Drugs with undisclosed chemical structures (42 P) E. Experimental anti-obesity drugs (5 C, 20 P) Experimental antiviral drugs (45 P)
Ads
related to: experimental prostate cancer drugs list